Vascular Surgery, Department of Surgery and Morphological Sciences Circolo University Hospital, University of Insubria School of Medicine, Varese, Italy.
Cardiac Surgery, Department of Surgery and Morphological Sciences Circolo University Hospital, University of Insubria School of Medicine, Varese, Italy.
Arch Med Sci. 2014 May 12;10(2):273-82. doi: 10.5114/aoms.2014.42579. Epub 2014 May 13.
To compare early and long-term outcomes of endovascular abdominal aortic aneurysm repair (EVAR) versus open repair (OPEN).
Prospective observational, per protocol, non-randomized, with retrospective analyses.
Between 2000 and 2005, a total of 311 patients having EVAR or OPEN repair of infrarenal abdominal aortic aneurysms were identified and included in this prospective single-center observational study. A propensity score-based optimal-matching algorithm was employed, and 138 patients undergoing EVAR procedures were matched (1: 1) to OPEN repair.
Open repair showed higher hospital mortality (17% vs. 6%, p = 0.004), respiratory failure (p < 0.026), transfusion requirement (p < 0.001), and intensive care unit admission (27% vs. 7%, p < 0.001), and longer hospitalization (p < 0.001). Median follow-up was 70 months (25(th) to 75(th) percentile, 24 to 101). Actuarial survival estimates at 1, 5 and 10 years were 93%, 74%, 49% for the OPEN group compared to 89%, 69%, 59% for the EVAR group (p = 0.465). A significant difference between groups was observed in younger patients (< 75 years) only (p < 0.044). Late complication and re-intervention rates were significantly higher in EVAR patients (p < 0.001 and p = 0.002, respectively). Freedom from late complications at 1, 5 and 10 years was 96%, 92%, 86%, and 84%, 70%, 64% for OPEN and EVAR procedures, respectively.
Our experience confirms the excellent results of the EVAR procedures, offering excellent early and long-term results in terms of safety and reduction of mortality. Patients < 75 years seem to benefit from EVAR not only in the immediate postoperative period but even in a long-term perspective.
比较血管内腹主动脉瘤修复术(EVAR)与开放修复术(OPEN)的早期和长期结果。
前瞻性观察,按方案,非随机,回顾性分析。
2000 年至 2005 年,共确定了 311 例接受肾下腹主动脉瘤 EVAR 或 OPEN 修复的患者,并将其纳入这项前瞻性单中心观察性研究。采用基于倾向评分的最优匹配算法,对 138 例接受 EVAR 手术的患者进行匹配(1:1),以匹配 OPEN 修复。
开放修复的住院死亡率更高(17%比 6%,p=0.004)、呼吸衰竭(p<0.026)、输血需求(p<0.001)和重症监护病房入住率(27%比 7%,p<0.001),住院时间更长(p<0.001)。中位随访时间为 70 个月(25(th)到 75(th)百分位,24 到 101)。OPEN 组 1、5 和 10 年的累积生存率估计值分别为 93%、74%、49%,EVAR 组分别为 89%、69%、59%(p=0.465)。仅在年龄较小的患者(<75 岁)中观察到两组之间的显著差异(p<0.044)。EVAR 患者的晚期并发症和再干预率明显更高(p<0.001 和 p=0.002)。1、5 和 10 年时,无晚期并发症的累积发生率分别为 96%、92%、86%和 84%、70%、64%,OPEN 和 EVAR 手术分别为 70%、64%。
我们的经验证实了 EVAR 手术的出色结果,在安全性和降低死亡率方面提供了极好的早期和长期结果。年龄<75 岁的患者不仅在术后即刻受益于 EVAR,甚至在长期来看也是如此。